Complete Filing Data
Oscar Health, Inc. reported Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents of $2.80 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Oscar Health, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$443.2M | $25.4M | -$270.7M | -$606.3M | -$572.6M | -$406.8M | -$261.2M |
| Revenue * | $28.6M | $20.6M | $21.4M | $64.9M | $5.4M | $0.00 | $488.2M |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $19.9M | -$3.1M | $11.0M | -$6.0M | -$4.6M | $906.0K | $17.0K |
| Operating Income Loss | -$396.4M | $57.3M | -$235.6M | -$589.9M | -$544.5M | -$402.3M | -$259.4M |
| Income Tax Expense Benefit | $5.6M | $7.3M | $3.3M | -$523.0K | $846.0K | $1.0M | $1.8M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$437.3M | $33.4M | -$267.3M | -$610.1M | -$570.6M | -$405.8M | -$259.4M |
| General And Administrative Expense | $28.9M | $32.1M | $30.7M | $15.3M | $265.1M | $166.7M | $110.7M |
| Comprehensive Income Net Of Tax | -$423.3M | $22.3M | -$259.7M | -$612.3M | -$577.2M | -$405.9M | -$261.2M |
| Net Income Loss Attributable To Noncontrolling Interest | $248.0K | $689.0K | $134.0K | -$3.3M | $1.2M | $0.00 | $0.00 |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$423.0M | $23.0M | -$259.6M | -$615.6M | -$576.0M | -$405.9M | -$261.2M |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $248.0K | $689.0K | $134.0K | -$3.3M | $1.2M | $0.00 | $0.00 |
| Nonoperating Income Expense | -$23.3M | -$105.0K | -$7.1M | $2.4M | -$1.2M | ||
| Deferred Income Tax Expense Benefit | $2.4M | -$2.3M | $58.0K | -$165.0K | -$101.0K | -$67.0K | -$426.0K |
| Interest Expense | $24.6M | $22.6M | $4.7M | $3.5M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$137.5M | -$228.4M | $275.3M | -$54.6M | $56.2M | $177.4M | -$65.4M | -$15.5M | -$39.8M | -$192.9M | -$112.2M | -$75.2M | -$211.5M | -$73.3M | -$88.9M | -$79.1M | -$40.9M | -$96.9M |
| Revenue * | $8.8M | $6.5M | $4.3M | $4.9M | $5.2M | $5.6M | $5.5M | $5.1M | $5.0M | $19.4M | $20.5M | $18.5M | $1.5M | $353.0K | $341.0K | $101.7M | $115.3M | $88.1M |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $2.7M | $4.1M | $11.4M | $28.7M | -$31.0K | -$3.9M | $2.4M | -$2.4M | $5.2M | $730.0K | -$3.0M | -$8.5M | $57.0K | -$644.0K | -$275.0K | |||
| Operating Income Loss | -$129.3M | -$230.5M | $297.1M | -$48.4M | $67.8M | $185.6M | -$58.2M | -$6.5M | -$25.4M | -$192.4M | -$106.5M | -$68.5M | -$211.7M | -$72.5M | -$64.0M | -$80.1M | -$39.4M | -$95.9M |
| Income Tax Expense Benefit | -$1.8M | -$5.0M | $12.7M | $2.1M | $4.6M | $996.0K | $915.0K | $1.2M | $2.0M | -$1.6M | $290.0K | $1.5M | -$597.0K | $589.0K | $965.0K | -$998.0K | $1.6M | $931.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$139.3M | -$233.5M | $288.2M | -$52.3M | $60.9M | $178.5M | -$64.8M | -$14.3M | -$37.6M | -$195.2M | -$111.8M | -$75.8M | -$212.1M | -$72.7M | -$87.9M | -$80.1M | -$39.4M | -$95.9M |
| General And Administrative Expense | $7.3M | $7.0M | $6.7M | $7.5M | $7.6M | $7.8M | $9.2M | $8.8M | $4.9M | $78.6M | $80.8M | $74.7M | $60.0M | $51.2M | $64.6M | $36.5M | $36.0M | $31.8M |
| Comprehensive Income Net Of Tax | -$134.8M | -$224.2M | $286.7M | -$25.9M | $56.2M | $173.5M | -$63.0M | -$17.9M | -$34.5M | -$192.2M | -$115.2M | -$83.7M | -$211.4M | -$74.0M | -$89.2M | -$80.1M | -$40.3M | -$95.4M |
| Net Income Loss Attributable To Noncontrolling Interest | -$34.0K | -$130.0K | $235.0K | $208.0K | $105.0K | $114.0K | -$305.0K | $103.0K | $144.0K | -$634.0K | $39.0K | -$2.2M | $0.00 | $0.00 | $0.00 | |||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$134.8M | -$224.4M | $286.9M | -$25.7M | $56.3M | $173.6M | -$63.3M | -$17.8M | -$34.4M | -$192.8M | -$115.1M | -$85.9M | -$211.4M | -$74.0M | -$89.2M | |||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -$34.0K | -$130.0K | $235.0K | $208.0K | $105.0K | $114.0K | -$305.0K | $103.0K | $144.0K | -$634.0K | $39.0K | -$2.2M | $0.00 | $0.00 | $0.00 | |||
| Nonoperating Income Expense | -$3.2M | $2.8M | -$2.9M | $1.9M | -$872.0K | -$1.2M | -$414.0K | -$1.6M | -$6.1M | $3.3M | $793.0K | -$3.1M | $0.00 | $0.00 | ||||
| Deferred Income Tax Expense Benefit | $36.0K | -$79.0K | -$183.0K | $0.00 | $8.0K | $120.0K | ||||||||||||
| Interest Expense | $5.9M | $6.1M | $6.1M | $6.1M | $6.1M | $6.1M | $4.2M | $398.0K | $228.0K | $3.7M | $0.00 | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $977.6M | $1.01B | $804.0M | $890.4M | $1.39B | -$1.30B | $0.00 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $2.80B | $1.55B | $1.89B | $1.58B | $1.13B | $843.1M | $353.4M | $370.4M |
| Liability For Claims And Claims Adjustment Expense | $1.46B | $1.36B | $966.0M | $937.7M | $513.6M | $311.9M | $156.6M | |
| Net Investment Income Gain Loss On Investments And Other Income | $202.9M | $185.7M | $155.4M | $27.6M | $2.3M | $7.8M | $19.3M | |
| Cash And Cash Equivalents At Carrying Value | $2.77B | $1.53B | $1.87B | $1.56B | $1.10B | $826.3M | $336.6M | |
| Increase Decrease Of Restricted Investments | -$4.3M | -$3.9M | $2.3M | -$1.1M | -$6.7M | $1.2M | $7.1M | |
| Gain Loss On Sale Of Investments | $1.3M | $23.0K | -$70.0K | -$1.3M | $209.0K | $1.2M | $481.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $1.25B | -$340.9M | $311.5M | $454.9M | $282.5M | $489.7M | -$17.0M | |
| Accretion Amortization Of Discounts And Premiums Investments | $29.8M | $26.9M | $29.4M | -$2.5M | -$8.0M | -$2.6M | $6.6M | |
| Restricted Cash And Cash Equivalents | $30.0M | $23.9M | $21.7M | $21.9M | $21.6M | $16.8M | $16.7M | |
| Risk Adjustment Transfer Receivables Current | $56.1M | $64.8M | $51.9M | $49.9M | $40.7M | $31.2M | ||
| Risk Adjustment Transfer Payable Current | $2.59B | $1.56B | $1.06B | $1.52B | $794.4M | $716.4M | ||
| Retained Earnings Accumulated Deficit | -$3.29B | -$2.85B | -$2.88B | -$2.61B | -$2.00B | -$1.43B | ||
| Restricted Cash And Investments Noncurrent | $33.0M | $30.9M | $29.9M | $27.5M | $28.1M | $26.5M | ||
| Reinsurance Payable | $3.6M | $41.3M | $61.0M | $427.6M | $205.2M | $343.3M | ||
| Property Plant And Equipment Net | $88.4M | $66.8M | $61.9M | $59.9M | $46.6M | $35.8M | ||
| Premiums And Other Receivables Net | $442.6M | $315.9M | $201.3M | $216.5M | $138.4M | $65.3M | ||
| Other Assets Noncurrent | $119.7M | $82.4M | $83.3M | $94.8M | $96.6M | $13.1M | ||
| Long Term Debt Noncurrent | $430.1M | $299.6M | $298.8M | $298.0M | $0.00 | $142.5M | ||
| Liabilities Current | $4.86B | $3.46B | $2.43B | $3.26B | $1.85B | $1.67B | ||
| Liabilities And Stockholders Equity | $6.33B | $4.84B | $3.60B | $4.53B | $3.32B | $2.27B | ||
| Liabilities | $5.34B | $3.82B | $2.80B | $3.63B | $1.93B | $1.82B | ||
| Assets Current | $4.61B | $2.85B | $3.06B | $4.12B | $2.31B | $1.87B | ||
| Assets | $6.33B | $4.84B | $3.60B | $4.53B | $3.32B | $2.27B | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $18.0M | -$1.8M | $1.3M | -$9.7M | -$3.7M | $879.0K | ||
| Accounts Payable And Accrued Liabilities Current | $649.7M | $432.4M | $273.4M | $297.8M | $234.8M | $137.5M | ||
| Liability For Future Policy Benefits Period Expense | $1.6M | -$25.0M | -$55.3M | $71.8M | $12.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $1.02B | $1.16B | $1.33B | $1.16B | $1.14B | $1.03B | $919.5M | $949.7M | $929.6M | $1.08B | $1.25B | $1.33B | $1.55B | $1.73B | $1.79B | -$1.14B | -$1.07B | -$1.03B | -$945.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $2.17B | $2.62B | $2.26B | $1.23B | $2.29B | $2.25B | $1.42B | $2.34B | $2.13B | $2.14B | $2.38B | $2.09B | $1.10B | $1.69B | $2.34B | $354.2M | $1.01B | $508.2M | |
| Liability For Claims And Claims Adjustment Expense | $1.56B | $1.55B | $1.47B | $1.36B | $1.25B | $1.25B | $910.4M | $855.7M | $954.1M | $995.8M | $880.5M | $761.3M | $497.3M | $407.3M | $358.1M | $276.5M | $241.5M | $253.0M | |
| Net Investment Income Gain Loss On Investments And Other Income | $53.2M | $54.0M | $46.1M | $50.3M | $50.0M | $43.0M | $42.4M | $41.5M | $36.1M | $5.3M | $2.3M | -$1.1M | $688.0K | $769.0K | $510.0K | $2.6M | $1.6M | $2.9M | |
| Cash And Cash Equivalents At Carrying Value | $2.15B | $2.60B | $2.24B | $1.21B | $2.27B | $2.23B | $1.40B | $2.32B | $2.11B | $2.11B | $2.36B | $2.07B | $1.08B | $1.67B | $2.32B | $337.4M | $988.5M | $491.7M | |
| Increase Decrease Of Restricted Investments | $0.00 | -$626.0K | $0.00 | -$611.0K | $0.00 | $356.0K | |||||||||||||
| Gain Loss On Sale Of Investments | $119.0K | $0.00 | -$43.0K | -$582.0K | $113.0K | $654.0K | |||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $709.2M | $361.1M | $550.7M | $964.4M | $1.49B | $154.8M | |||||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $7.7M | $6.2M | $7.3M | -$1.9M | -$1.1M | -$155.0K | |||||||||||||
| Restricted Cash And Cash Equivalents | $23.9M | $24.4M | $23.8M | $25.8M | $23.1M | $22.3M | $21.8M | $21.1M | $21.7M | $22.3M | $21.8M | $21.4M | $21.2M | $16.8M | $16.8M | $16.8M | $16.5M | ||
| Risk Adjustment Transfer Receivables Current | $92.6M | $87.6M | $87.1M | $63.5M | $72.1M | $62.0M | $54.1M | $60.3M | $48.1M | $44.3M | $54.5M | $50.6M | $43.1M | $39.9M | $37.8M | ||||
| Risk Adjustment Transfer Payable Current | $1.77B | $2.65B | $1.95B | $1.08B | $1.78B | $1.34B | $751.2M | $1.98B | $1.81B | $1.08B | $1.50B | $1.17B | $613.2M | $1.04B | $922.1M | ||||
| Retained Earnings Accumulated Deficit | -$2.94B | -$2.80B | -$2.58B | -$2.70B | -$2.64B | -$2.70B | -$2.73B | -$2.66B | -$2.65B | -$2.38B | -$2.19B | -$2.07B | -$1.80B | -$1.59B | -$1.51B | ||||
| Restricted Cash And Investments Noncurrent | $27.9M | $31.1M | $31.0M | $30.1M | $29.9M | $29.8M | $27.3M | $27.3M | $27.3M | $27.5M | $27.2M | $27.2M | $27.8M | $26.5M | $26.4M | ||||
| Reinsurance Payable | $7.3M | $13.4M | $23.6M | $51.1M | $60.1M | $61.9M | $67.3M | $67.6M | $40.5M | $435.6M | $430.9M | $392.2M | $221.3M | $248.1M | $260.1M | ||||
| Property Plant And Equipment Net | $83.4M | $77.7M | $72.0M | $66.6M | $64.0M | $61.4M | $62.0M | $63.1M | $64.1M | $56.5M | $50.9M | $48.6M | $43.4M | $40.9M | $39.0M | ||||
| Premiums And Other Receivables Net | $445.5M | $465.4M | $488.8M | $300.6M | $398.4M | $342.9M | $207.1M | $193.1M | $186.0M | $215.5M | $174.2M | $157.3M | $117.5M | $85.6M | $75.9M | ||||
| Other Assets Noncurrent | $120.6M | $116.3M | $93.6M | $84.4M | $87.3M | $87.2M | $88.9M | $92.3M | $95.2M | $97.1M | $98.1M | $97.2M | $18.8M | $19.4M | $19.5M | ||||
| Long Term Debt Noncurrent | $686.3M | $299.9M | $299.7M | $299.4M | $299.2M | $299.0M | $298.6M | $298.4M | $298.2M | $297.8M | $297.6M | $297.4M | $0.00 | $0.00 | $0.00 | ||||
| Liabilities Current | $3.98B | $4.87B | $4.15B | $2.95B | $3.50B | $3.02B | $2.06B | $3.24B | $3.18B | $2.85B | $3.13B | $2.64B | $1.62B | $1.97B | $1.81B | ||||
| Liabilities And Stockholders Equity | $5.75B | $6.38B | $5.84B | $4.48B | $5.01B | $4.42B | $3.35B | $4.56B | $4.48B | $4.31B | $4.75B | $4.35B | $3.17B | $3.71B | $3.59B | ||||
| Liabilities | $4.72B | $5.22B | $4.51B | $3.32B | $3.87B | $3.38B | $2.43B | $3.61B | $3.55B | $3.22B | $3.50B | $3.02B | $1.62B | $1.97B | $1.81B | ||||
| Assets Current | $3.76B | $4.31B | $3.77B | $2.37B | $3.36B | $3.50B | $2.99B | $4.19B | $4.13B | $3.93B | $4.26B | $3.67B | $2.24B | $2.82B | $3.18B | ||||
| Assets | $5.75B | $6.38B | $5.84B | $4.48B | $5.01B | $4.42B | $3.35B | $4.56B | $4.48B | $4.31B | $4.75B | $4.35B | $3.17B | $3.71B | $3.59B | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $16.4M | $13.7M | $9.6M | $26.1M | -$2.6M | -$2.6M | -$4.5M | -$6.9M | -$4.5M | -$14.5M | -$15.2M | -$12.2M | $17.0K | -$40.0K | $604.0K | ||||
| Accounts Payable And Accrued Liabilities Current | $556.7M | $583.9M | $634.0M | $395.5M | $347.5M | $303.2M | $260.1M | $261.5M | $299.5M | $252.4M | $226.3M | $220.5M | $159.2M | $135.3M | $121.0M | ||||
| Liability For Future Policy Benefits Period Expense | -$3.2M | -$819.0K | -$14.0K | -$6.5M | -$4.5M | -$3.2M | -$4.7M | -$921.0K | -$9.5M | -$4.1M | -$244.0K | -$18.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $87.7M | $109.8M | $159.7M | $112.3M | $86.3M | $35.9M | $33.6M |
| Proceeds From Stock Options Exercised | $55.0M | $68.4M | $4.0M | $1.3M | $49.6M | $19.3M | $873.0K |
| Proceeds From Sale Of Available For Sale Securities Debt | $134.2M | $25.3M | $31.9M | $360.6M | $624.1M | $489.5M | $716.2M |
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $670.7M | $744.8M | $1.41B | $633.5M | $430.7M | $182.1M | $345.0M |
| Payments To Acquire Productive Assets | $36.4M | $27.9M | $25.6M | $29.0M | $25.9M | $14.0M | $26.0M |
| Payments To Acquire Available For Sale Securities Debt | $1.01B | $2.13B | $837.0M | $1.19B | $1.81B | $1.00B | $877.7M |
| Net Cash Provided By Used In Operating Activities | $1.09B | $978.2M | -$272.2M | $380.3M | -$181.7M | $222.7M | -$165.4M |
| Net Cash Provided By Used In Investing Activities | -$241.1M | -$1.39B | $577.2M | -$226.5M | -$774.5M | -$344.7M | $150.5M |
| Net Cash Provided By Used In Financing Activities | $399.2M | $68.4M | $6.4M | $301.1M | $1.24B | $611.7M | -$2.1M |
| Increase Decrease In Unearned Premiums | $91.8M | $8.5M | -$13.1M | $4.0M | $3.1M | $46.6M | $5.5M |
| Increase Decrease In Risk Adjustment Transfer Receivables | -$8.7M | $12.9M | $2.1M | $9.2M | $9.5M | $6.0M | $25.1M |
| Increase Decrease In Risk Adjustment Transfer Payable | $1.03B | $501.4M | -$460.6M | $723.1M | $78.0M | $417.7M | $91.7M |
| Increase Decrease In Reinsurance Recoverable | -$191.8M | $50.3M | -$651.7M | $460.9M | -$147.4M | $63.3M | $305.7M |
| Increase Decrease In Reinsurance Payables | -$37.8M | -$19.7M | -$366.6M | $222.4M | -$138.1M | -$89.2M | $274.6M |
| Increase Decrease In Premiums Receivable | $101.9M | $114.3M | $13.4M | $81.0M | $67.0M | $35.3M | $8.6M |
| Increase Decrease In Other Operating Assets | $27.1M | $11.5M | -$11.3M | $243.0K | $11.3M | -$2.2M | $11.9M |
| Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve | $98.7M | $390.7M | $28.3M | $424.1M | $201.7M | $155.4M | $21.4M |
| Increase Decrease In Future Policy Benefit Reserves | $0.00 | -$5.8M | $1.6M | -$25.0M | -$55.3M | $71.8M | $12.6M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $205.5M | $152.8M | -$29.2M | $57.8M | $98.6M | $75.8M | $7.5M |
| Depreciation Depletion And Amortization | $28.9M | $32.1M | $30.7M | $15.3M | $14.6M | $11.3M | $6.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $25.0M | $25.9M | $71.5M | $27.7M | $20.6M | $18.3M | $19.1M | $7.3M | $6.6M | $8.1M |
| Proceeds From Stock Options Exercised | $5.7M | $27.3M | $35.0K | $560.0K | $29.7M | $442.0K | ||||
| Proceeds From Sale Of Available For Sale Securities Debt | $15.8M | $0.00 | $15.1M | $169.4M | $83.8M | $163.9M | ||||
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $155.9M | $261.4M | $330.5M | $105.8M | $134.2M | $39.2M | ||||
| Payments To Acquire Productive Assets | $9.0M | $6.0M | $7.4M | $6.2M | $6.6M | $4.0M | ||||
| Payments To Acquire Available For Sale Securities Debt | $336.9M | $556.7M | $202.7M | $166.8M | $245.7M | $150.8M | ||||
| Net Cash Provided By Used In Operating Activities | $878.5M | $634.4M | $414.7M | $562.8M | $317.7M | $106.4M | ||||
| Net Cash Provided By Used In Investing Activities | -$174.2M | -$300.6M | $135.5M | $102.8M | -$34.3M | $48.0M | ||||
| Net Cash Provided By Used In Financing Activities | $4.9M | $27.3M | $506.0K | $298.8M | $1.21B | $442.0K | ||||
| Increase Decrease In Unearned Premiums | -$3.5M | -$376.0K | -$5.6M | -$344.0K | $42.0K | -$2.9M | ||||
| Increase Decrease In Risk Adjustment Transfer Receivables | $22.3M | $10.1M | -$1.7M | $10.0M | $6.6M | $11.2M | ||||
| Increase Decrease In Risk Adjustment Transfer Payable | $396.1M | $279.1M | $292.7M | $371.7M | $205.7M | $158.8M | ||||
| Increase Decrease In Reinsurance Recoverable | -$104.0M | $1.7M | -$440.7M | $153.7M | -$225.4M | $92.9M | ||||
| Increase Decrease In Reinsurance Payables | -$17.7M | $914.0K | -$387.2M | $187.0M | -$83.3M | $119.9M | ||||
| Increase Decrease In Premiums Receivable | $164.2M | $140.6M | -$21.9M | $18.9M | $10.5M | $75.3M | ||||
| Increase Decrease In Other Operating Assets | $13.3M | $6.3M | $4.5M | -$455.0K | $6.3M | $14.8M | ||||
| Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve | $108.8M | $282.4M | $16.3M | $247.7M | $46.2M | $96.4M | ||||
| Increase Decrease In Future Policy Benefit Reserves | $0.00 | -$1.4M | -$14.0K | -$3.2M | -$9.5M | -$18.0K | ||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $199.6M | $28.5M | $714.0K | -$14.7M | -$11.7M | $15.5M | ||||
| Depreciation Depletion And Amortization | $6.7M | $7.8M | $4.9M | $3.8M | $3.4M | $2.5M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 262.4M | 240.4M | 221.7M | 212.5M | 179.0M | 29.3M | 28.8M |
| Weighted Average Number Of Diluted Shares Outstanding | 262.4M | 265.9M | 221.7M | 212.5M | 179.0M | 29.3M | 28.8M |
| Earnings Per Share Diluted | $-1.69 | $0.10 | $-1.22 | $-2.85 | $-3.20 | $-14.16 | $-9.06 |
| Earnings Per Share Basic | $-1.69 | $0.11 | $-1.22 | $-2.85 | $-3.20 | $-14.16 | $-9.06 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 259.3M | 255.5M | 251.3M | 243.1M | 238.7M | 231.4M | 223.1M | 219.4M | 216.9M | 212.8M | 211.3M | 210.5M | 208.2M | 207.5M | 88.9M | 29.0M | 28.9M | 28.9M |
| Weighted Average Number Of Diluted Shares Outstanding | 259.3M | 255.5M | 305.9M | 243.1M | 304.0M | 293.8M | 223.1M | 219.4M | 216.9M | 212.8M | 211.3M | 210.5M | 208.2M | 207.5M | 88.9M | 29.0M | 28.9M | 28.9M |
| Earnings Per Share Diluted | $-0.53 | $-0.89 | $0.92 | $-0.22 | $0.20 | $0.62 | $-0.29 | $-0.07 | $-0.18 | $-0.91 | $-0.53 | $-0.36 | $-1.02 | $-0.35 | $-1.00 | $-2.72 | $-1.42 | $-3.36 |
| Earnings Per Share Basic | $-0.53 | $-0.89 | $1.10 | $-0.22 | $0.24 | $0.77 | $-0.29 | $-0.07 | $-0.18 | $-0.91 | $-0.53 | $-0.36 | $-1.02 | $-0.35 | $-1.00 | $-2.72 | $-1.42 | $-3.36 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Premiums Earned Net | $11.47B | $8.97B | $5.69B | $3.87B | $1.83B | $455.0M | $468.9M |
| Policyholder Benefits And Claims Incurred Net | $10.02B | $7.33B | $4.64B | $3.28B | $1.62B | $309.4M | $408.3M |
| Benefits Losses And Expenses | $12.10B | $9.12B | $6.10B | $4.55B | $2.38B | $865.1M | $747.6M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $166.8M | $112.3M | $86.3M | $35.9M | |||
| Interest Paid Net | $12.8M | $33.7M | $23.2M | $10.1M | $4.3M | $0.00 | $0.00 |
| Amortization Of Financing Costs | $1.6M | $778.0K | $778.0K | $713.0K | $329.0K | $327.0K | $0.00 |
| Unearned Premiums | $166.2M | $74.4M | $65.9M | $79.0M | $75.0M | $71.9M | |
| Reinsurance Recoverables On Paid And Unpaid Losses | $99.8M | $291.5M | $241.2M | $892.9M | $432.0M | $579.4M | |
| Additional Paid In Capital | $4.26B | $3.87B | $3.68B | $3.51B | $3.39B | $133.3M | |
| Premiums Earned Before Premiums Ceded | $5.70B | $5.33B | $2.71B | $1.67B | $1.04B | ||
| Other Insurance Expense Net | $824.5M | $706.4M | $410.4M | $216.5M | $167.9M | ||
| Federal And State Assessment Expense | $290.7M | $281.5M | $139.1M | $81.5M | $48.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Premiums Earned Net | $2.92B | $2.80B | $3.00B | $2.37B | $2.16B | $2.09B | $1.39B | $1.47B | $1.43B | $953.7M | $994.6M | $955.4M | $441.7M | $528.2M | $368.5M | $99.1M | $113.8M | $85.2M |
| Policyholder Benefits And Claims Incurred Net | $2.59B | $2.55B | $2.26B | $2.00B | $1.71B | $1.55B | $1.16B | $1.18B | $1.09B | $852.7M | $808.6M | $734.6M | $453.6M | $419.9M | $268.0M | $85.4M | $55.5M | $84.2M |
| Benefits Losses And Expenses | $3.12B | $3.09B | $2.75B | $2.47B | $2.15B | $1.96B | $1.50B | $1.53B | $1.50B | $1.17B | $1.12B | $1.04B | $655.7M | $601.8M | $433.4M | $181.8M | $154.7M | $184.1M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $31.3M | $27.3M | $30.4M | $35.5M | $73.2M | $28.6M | $27.0M | $27.7M | $20.6M | $18.3M | $19.1M | $7.3M | $6.6M | $8.1M | ||||
| Interest Paid Net | $154.0K | $11.1M | $11.3M | $261.0K | $3.6M | $0.00 | ||||||||||||
| Amortization Of Financing Costs | $194.0K | $194.0K | $194.0K | $129.0K | $329.0K | $0.00 | ||||||||||||
| Unearned Premiums | $77.1M | $69.5M | $70.9M | $66.1M | $60.0M | $65.5M | $71.6M | $73.1M | $73.3M | $75.1M | $72.7M | $74.7M | $56.2M | $63.9M | $71.9M | |||
| Reinsurance Recoverables On Paid And Unpaid Losses | $159.4M | $192.7M | $187.5M | $273.3M | $241.3M | $242.9M | $277.8M | $353.9M | $452.2M | $824.5M | $740.2M | $585.7M | $413.8M | $400.2M | $354.0M | |||
| Additional Paid In Capital | $3.95B | $3.95B | $3.90B | $3.84B | $3.79B | $3.74B | $3.65B | $3.62B | $3.58B | $3.48B | $3.45B | $3.42B | $3.36B | $3.32B | $3.30B | |||
| Premiums Earned Before Premiums Ceded | $1.39B | $1.48B | $1.43B | $1.32B | $1.37B | $1.32B | $673.5M | $723.9M | $610.1M | $414.5M | $393.5M | $424.4M | ||||||
| Other Insurance Expense Net | $192.9M | $197.8M | $227.4M | $175.0M | $170.2M | $165.4M | $111.3M | $94.8M | $79.8M | $38.7M | $39.6M | $40.9M | ||||||
| Federal And State Assessment Expense | $69.9M | $72.6M | $73.9M | $71.1M | $68.7M | $69.9M | $35.5M | $36.9M | $30.5M | $20.5M | $19.0M | $22.3M |
Most recent annual filing with the SEC: February 13, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.